Analyst firms · Wolfe Research · MET
Wolfe Research MET price target and rating history
MetLife Inc. (MET) · Finance
Wolfe Research rates MetLife Inc. (MET) Outperform with a $95 price target, as of its latest action on Sep 16, 2025. It has published 3 rating actions on MET since January 2022, including 1 upgrade and 0 downgrades. Across 3 firms with a MET price target in the last 12 months, the median target is $101.
- Current rating
- Outperform
- Price target
- $95
- Median target, all firms
- $101
- Actions on MET
- 3
Wolfe Research price target on MET
Every Wolfe Research rating on MET
- Sep 16, 2025
- Jun 23, 2022
- Jan 21, 2022
How other firms rate MET
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Overweight | $110 | Sep 22, 2026 |
| Evercore ISI | In-line | $97 | Jan 6, 2026 |
| Mizuho | Outperform | $101 | Dec 16, 2025 |
Questions about Wolfe Research and MET
- What is Wolfe Research's price target for MET?
- Wolfe Research's latest stated price target for MetLife Inc. (MET) is $95, from its action on Sep 16, 2025.
- What is Wolfe Research's rating on MET?
- Wolfe Research rates MET Outperform, a bullish rating, as of Sep 16, 2025.
- When did Wolfe Research last change its view on MET?
- On Sep 16, 2025, Wolfe Research starts coverage at Outperform, price target $95.
- How does Wolfe Research's MET target compare with other analysts?
- Across 3 firms with a MET price target in the last 12 months, the median target is $101.
More MET rating histories
All Wolfe Research ratingsMET news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.